An investigation on behalf of investors in NYSE:BIO shares over potential securities laws violations by Bio-Rad Laboratories, Inc. and certain of its directors and officers was announced.
Investors who purchased shares of Bio-Rad Laboratories, Inc. (NYSE:BIO), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Bio-Rad Laboratories, Inc. (NYSE:BIO) concerning whether certain statements by Bio-Rad Laboratories, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Hercules, CA based Bio-Rad Laboratories, Inc. is a manufacturer and distributor of life science research and clinical diagnostics products.
On May 4, 2010, Bio-Rad Laboratories, Inc disclosed that it had self-reported to the U.S. Securities and Exchange Commission (“SEC”) and the U.S. Department of Justice (“DOJ”) after an internal review identified certain practices that violated the Foreign Corrupt Practices Act of 1977.
On November 3, 2014, Bio-Rad Laboratories, Inc agreed to pay $55 million to settle allegations by U.S. authorities that the Company’s subsidiaries had paid bribes to foreign officials in Russia, Thailand and Vietnam and falsified records to mask these bribes as legitimate expenses.
On May 27, 2015, Bio-Rad Laboratories’ former General Counsel Sanford Wadler filed a lawsuit alleging that he was fired in 2013 after raising concerns to the Company’s audit committee about bribery practices in China and for refusing to turn a blind eye to corruption.
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) grew from $90.19 per share in September 2011 to as high as $194.20 per share on January 10, 2017.
On January 31, 2017, NYSE:BIO shares closed at $190.08 per share.
Those who purchased NYSE:BIO shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego